10x Genomics, Inc. Stock

10xgenomics.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $222.59MM

10x Genomics is a biotechnology company offering a range of products including software and hardware all aimed at better understanding biological systems.

Register To Buy and Sell Shares

For more details on financing and valuation for 10x Genomics, Inc., register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access 10x Genomics, Inc.’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like 10x Genomics, Inc..

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Serge Saxonov
Chief Executive Officer, Co-founder
Brad Crutchfield
Chief Commercial Officer
Ben Hindson
Chief Scientific Officer, President, Co-founder
Justin McAnear
Chief Financial Officer
Jean Philibert
Chief People Officer
Sam Ropp
Senior Vice President, Global Sales
Jonathan Schimmel
Vice President, Global Support and Sales Operations
Michael Schnall-Levin
Senior Vice President, R&D, Founding Scientist
Alexander Wong
Senior Vice President, Product, Software & Infrastructure
Paul Wyatt
Vice President, Operations
Eric Whitaker
General Counsel

Board Members

Serge Saxonov
Shehnaaz Suliman, M.D., M.Phil., M.B.A.
Sri Kosaraju
Penumbra
Mathai Mammen
Janssen
Bryan Roberts, Ph.D.
Venrock
John Stuelpnagel
Ben Hindson

News Highlights

10x Genomics Prices Initial Public Offering | FinSMEs
10x Genomics, a Pleasonton, Calif.-based company that build products combining hardware, chemistry, and software to give single cell and spatial views of biological systems, priced its initial public offering
Updated on: Feb 28, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.